Member Info for LUCAN

Is the Israeli inhaler based on Interferon-Beta, and hence related to Synairgen's product ,do you know?

'We are confident that this amendment will expedite the advancement of the SRA737 programme in a timely manner', is what SAR said about the revised terms.
If that means anything at all, it means that Sierra undertook to make significant progress not later than a specified date, not far distant - probably around March/April.
If no such undertaking was received, then the negotiators - CRUK - must be thoroughly incompetent, which I don 't believe. So we should not have long to wait.

The point is, as I am sure you understand, this is a game changer if it works reliably outside the lab.
If not, then not.
One would like to hear a bit more than 'still trying'.

Still testing, still 'a wide range of possible outcomes' as in November.
Sounds like there may be problems?

https://www.invaluable.com/auction-lot/egyptian-copper-baboon-headed-thoth-figure-4-c-bf44017bf7
This might interest you. Mascot for your boat?
Apparently he is the god of writing and thinking. Very fitting.

Do you still think Virolens is on course to deliver? Soon enough to be useful?
It seems to be taking a long time.
Noticeable that the share price never seems to hold its gains, even small ones - i.e. someone is selling at every opportunity.

Permit me to point out that article was dated September 17. Almost 4 months ago.
#Since then we have heard nothing - or actually less than nothing, since the Heathrow test claim has been denied.

Thanks for posting those documents. It helps a lot.

Two of the report's three authors (but not the lead author) are founders of Synairgen.

As a matter of interest, which Communist system did you live under for 27 years - if you don't mind explaining?

https://www.lse.co.uk/rns/AVCT/license-agreement-with-point-biopharma-inc-4ltd3yd383pyl32.html
Hope all is as well as may be. This is to improve targeting of radiotherapy, I think.

Describing identifiable people as criminals is actionable at law. You can be sued for a lot of money. Take care.

I hope your judgement of stocks is better than your taste in music.

Now seven 1m buys today and some smaller.
Not big money by any means, but not quite small change either.

Three 1m buys this morning.
Someone still has hope.

If you read the link supplied by willdo, you will see that the relevant fallback date for full payment is 31.12.21, not '20.
So no panic.

https://www.lse.co.uk/rns/AVCT/submission-of-cta-for-ava6000-pro-doxorubixin-ghqk7f1sxpmeq9f.html
Here's another that might be of interest, targeting a wide range of solid tumours, human trials pending soon.
Best wishes

I think that's right.

Sorry, Thoth2 not Thioth2

This might interest you. The company is SAREUM (SAR). I think they are planning human trials next year. The poster is Thioth2, very knowledgeable. "SDC-1802 shows compelling activity in disease models of: blood cancers that are dependent on TYK2/STAT signalling (e.g. T-ALL and B-cell lymphoma); solid tumours dependent on TYK2-dependent interleukin signalling (e.g. kidney and colon cancers) and; solid tumours via local immune system modulation (including kidney, colon, pancreatic and skin cancers)." That covers just about everything I think.
Best wishes